Alkermes (ALKS) Goodwill & Intangibles (2011 - 2026)
Alkermes (ALKS) posted quarterly Goodwill & Intangibles of $2.3 billion for Q2 2026, up 2650.53% year-over-year from $83.9 million in Q2 2025, and down 3.54% quarter-over-quarter from $2.4 billion in Q1 2026.
Alkermes (ALKS) Goodwill & Intangibles (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Goodwill & Intangibles for 16 consecutive years, with $2.3 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Goodwill & Intangibles rose 2650.53% year-over-year to $2.3 billion; the TTM figure through Jun 2026 stood at $2.3 billion (up 2650.53% YoY), while the FY2025 annual figure was $83.8 million, changed 0.09% from the prior year.
- Goodwill & Intangibles eased to $2.3 billion in Q2 2026 per ALKS's latest filing, from $2.4 billion in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $2.4 billion in Q1 2026 and bottomed at $83.8 million in Q4 2025.
- Historically, Goodwill & Intangibles has averaged $598.0 million across 5 years, with a median of $666.8 million in 2022.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles sank 87.6% — and 2026, when it surged 2750.96%.
- Alkermes' Goodwill & Intangibles stood at $666.8 million in 2022, then tumbled by 87.25% to $85.0 million in 2023, then retreated by 1.3% to $83.9 million in 2024, then dropped by 0.09% to $83.8 million in 2025, then jumped by 2651.78% to $2.3 billion in 2026.
- Business Quant data shows ALKS's Goodwill & Intangibles at $2.3 billion in Q2 2026, $2.4 billion in Q1 2026, and $83.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.31 Bn |
| Mar 31, 2026 | 2.39 Bn |
| Dec 31, 2025 | 83.84 Mn |
| Sep 30, 2025 | 83.86 Mn |
| Jun 30, 2025 | 83.88 Mn |
| Mar 31, 2025 | 83.90 Mn |
| Dec 31, 2024 | 83.92 Mn |
| Sep 30, 2024 | 83.93 Mn |
| Jun 30, 2024 | 83.95 Mn |
| Mar 31, 2024 | 666.78 Mn |
| Dec 31, 2023 | 85.02 Mn |
| Sep 30, 2023 | 676.62 Mn |
| Jun 30, 2023 | 676.62 Mn |
| Mar 31, 2023 | 676.62 Mn |
| Dec 31, 2022 | 666.78 Mn |
| Sep 30, 2022 | 676.62 Mn |
| Jun 30, 2022 | 676.62 Mn |
| Mar 31, 2022 | 676.62 Mn |
| Dec 31, 2021 | 676.62 Mn |
| Sep 30, 2021 | 676.62 Mn |